Alnylam Pharmaceuticals (ALNY) Enterprise Value (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.46% |
| Dec 31, 2025 | -6.75% |
| Sep 30, 2025 | 4.65% |
| Jun 30, 2025 | -178.29% |
| Mar 31, 2025 | -5.12% |
| Dec 31, 2024 | 11.86% |
| Sep 30, 2024 | 57.62% |
| Jun 30, 2024 | -10.79% |
| Mar 31, 2024 | 2.81% |
| Dec 31, 2023 | -1.35% |
| Sep 30, 2023 | -249.73% |
| Jun 30, 2023 | 66.50% |
| Mar 31, 2023 | -128.04% |
| Dec 31, 2022 | 60.01% |
| Sep 30, 2022 | -7.82% |
| Jun 30, 2022 | 5.79% |
| Mar 31, 2022 | 6.88% |
| Dec 31, 2021 | -103.23% |
| Sep 30, 2021 | -46.13% |
| Jun 30, 2021 | 51.69% |
| Mar 31, 2021 | 9.81% |
| Dec 31, 2020 | -3.13% |
| Sep 30, 2020 | 3.40% |
| Jun 30, 2020 | -41.03% |
| Mar 31, 2020 | 14.46% |
| Dec 31, 2019 | 11.41% |
| Sep 30, 2019 | 10.68% |
| Jun 30, 2019 | -54.82% |
| Mar 31, 2019 | -14.66% |
| Dec 31, 2018 | -227.32% |
| Sep 30, 2018 | 11.22% |
| Jun 30, 2018 | 76.18% |
| Mar 31, 2018 | 7.34% |
| Dec 31, 2017 | -78.44% |
| Sep 30, 2017 | -2.71% |
| Jun 30, 2017 | -65.78% |
| Mar 31, 2017 | 10.07% |
| Dec 31, 2016 | 11.47% |
| Sep 30, 2016 | 17.03% |
| Jun 30, 2016 | -217.89% |
| Mar 31, 2016 | -14.16% |
| Dec 31, 2015 | -23.71% |
| Sep 30, 2015 | 13.02% |
| Jun 30, 2015 | 77.67% |
| Mar 31, 2015 | -60.60% |
| Dec 31, 2014 | -1.94% |
| Sep 30, 2014 | 2.42% |
| Jun 30, 2014 | 9.04% |
| Mar 31, 2014 | -170.67% |
| Dec 31, 2013 | -26.88% |
| Sep 30, 2013 | 7.59% |
| Jun 30, 2013 | 11.15% |
| Mar 31, 2013 | -92.17% |
| Dec 31, 2012 | 46.21% |
| Sep 30, 2012 | -373.00% |
| Jun 30, 2012 | 75.75% |
| Mar 31, 2012 | -35.99% |
| Dec 31, 2011 | 15.38% |
| Sep 30, 2011 | 20.61% |
| Jun 30, 2011 | 10.91% |
| Mar 31, 2011 | -4.94% |
| Dec 31, 2010 | -0.76% |
| Sep 30, 2010 | 10.74% |
| Jun 30, 2010 | -125.49% |
| Mar 31, 2010 | 59.15% |
| Dec 31, 2009 | -186.89% |
| Sep 30, 2009 | 33.67% |